FDA to Assess First Peanut Allergy Drug
In one clinical trial, kids who took Palforzia for a year were eventually able to tolerate the equivalent of two peanuts, the Washington Post reported. WebMD Health
Drug
Zantac Heartburn Drug May Contain Carcinogen: FDA
While preliminary tests found low levels of the nitrosamine impurity N-nitrosodimethylamine (NDMA) in some ranitidine products, the FDA said this does not mean patients taking the drugs should stop using them now. WebMD Health
FDA Approves Drug for Most Deadly Form of TB
The FDA approval sprang from a groundbreaking trial of 107 patients in South Africa who had been diagnosed with XDR-TB. Six months after treatment, 89% of the patients were cured, which is far higher than typical success rates for treatment of this often lethal strain of TB WebMD Health
Pure CBD Won’t Make You Fail a Drug Test, But…
Researchers found that CBD, or cannabidiol, did not react with either of two commercially available tests used to screen for marijuana use. However, another cannabis compound — cannabinol (CBN) — did. WebMD Health
FDA: Pricey Drug Approved on Manipulated Data
The FDA approved the gene therapy Zolgensma to treat children with a severe form of spinal muscular atrophy. The drug costs $ 2.125 million for a one-time treatment, CBS News reported. WebMD Health
Drug Duo May Be a Weapon Against a Common Leukemia
The phase 3 trial of more than 500 U.S. patients with chronic lymphocytic leukemia (CLL) found that a combination of rituximab and ibrutinib extended patient survival. WebMD Health
Study Casts Doubt on Safety of Herbal Drug Kratom
Kratom, made from the leaves of a Southeast Asian plant, is usually used to treat pain and addiction. But poison control center data shows it has been tied to seizures, withdrawal, hallucinations, agitation and rapid heart rate, researchers report. WebMD Health
FDA OKs 1st Drug for Sinusitis With Nasal Polyps
Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis — defined as a prolonged inflammation of the sinuses and nasal cavity, the FDA said. WebMD Health
FDA Approves Second Drug For Women With Low Libido
The FDA approved Vyleesi, the second medication so far approved to help women with low sexual desire. WebMD Health
FDA Approves Second Drug For Women With Low Libido
The FDA approved Vyleesi, the second medication so far approved to help women with low sexual desire. WebMD Health